DURING MODI 3.0, SWARNIM BHARAT IS THE TARGET

It will be a stable NDA government headed by a Prime Minister who has a passionate commitment to making India the third largest economy in the world by 2029.

- 

2024 is not a good year for ruling parties to face a national election. In the United States, President Joe Biden trails Donald Trump in several polls, while UK Prime Minister Rishi Sunak appears headed for disastrous losses by the Conservative Party at the hands of the Labour Party. There has been much commentary about how the BJP lost more than 60 Lok Sabha seats during the 2024 elections. However, the NDA has returned to power, and Prime Minister Narendra Modi is set to begin a third term in office within hours, a repeat performance unlikely to be replicated by Sunak or possibly Biden. Given the reformist credentials of key allies such as Chandrababu Naidu, the odds favour a vigorous push towards the reforms needed for double digit growth during Modi 3.0. Double digit growth is a better vote catcher than any other. Unless India maintains a double digit growth path throughout Modi 3.0, youth unemployment will rise and so will the risk of unrest instigated by outside elements, a fact that Prime Minister Modi has begun working to address.

The entire term of Modi 2.0 was marked by turbulence caused mainly by external crises. 2019 onwards, the world entered a period of extreme turbulence. That was when Covid-19 first struck in Wuhan, although the information was suppressed by the Chinese government until it had become too obvious to ignore by January 2020 that a new virus was spreading. Unlike the 2003 SARS outbreak, which was swiftly made public by President Hu Jintao and had minimal casualties, the 2019 SARS-Cov-2 outbreak was mishandled disastrously by CCP General Secretary Xi Jinping, who was the originator of the Total Lockdown policy, that was first imposed in and around Wuhan. Soon, lockdowns were enforced across the world. Vaccine research and production were fasttracked, with India emerging as the biggest supplier of vaccines to the Global South.